Physician profile
Adam Wanner
NPI 1013925684
$20,484.14
in general payments reported to CMS, 2019-2025
7 companies · $30.95 in 2025
The $30.95 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,618 · 2020: $6,211 · 2021: $5,259 · 2022: $22.90 · 2024: $1,343 · 2025: $30.95.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,343 · Food and Beverage: $30.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,342.50 |
| Food and Beverage | $30.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $5,837.55 | 2019 | |
| Merck Sharp & Dohme LLC | $5,780.29 | 2019-2021 | |
| Astrazeneca Ab | $3,759.00 | 2021 | |
| Astrazeneca Uk Limited | $3,695.50 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $1,357.95 | 2020-2024 | |
| United Therapeutics Corporation | $30.95 | 2025 | Tyvaso |
| Mallinckrodt Hospital Products INC. | $22.90 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Wanner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.